Phase 1 Study With Sorafenib and Sirolimus

Clinical trial NCT00509613 · COMPLETED

Trial details

NCT number: NCT00509613
Sponsor: Radboud University Medical Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Refractory to Standard Therapies

Start date: 2007-06-01
Primary completion: 2009-05-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.